Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2322 of 6351
-
Ultrasound may replace costly CT scans for lung disease in arthritis patients
Diagnosis Recruiting nowRheumatoid arthritis is an autoimmune disease that can affect various organs, including the lungs, and lead to rheumatoid arthritis-interstitial lung disease (RA-ILD). RA-ILD is responsible for increased mortality in rheumatoid arthristis (RA) patients. The prevalence of RA-ILD…
Sponsor: University Hospital, Tours • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
New scan could spot breast cancer spread without surgery
Diagnosis CompletedThis study aims to explore the diagnostic performance of \[18F\]FES PET/CT for the evaluation of axillary lymph node metastasis in patients with ER-positive breast cancer having clinically suspected or confirmed axillary lymph node metastasis.
Phase 2 • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
New study aims to sharpen diagnosis of rare brain disease
Diagnosis Recruiting nowAnti-myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD) is a rare inflammatory autoimmune disease. In addition, since the international MOGAD group proposed live-cell based assays for MOGAD diagnosis in 2023, there are still no real-world cohort validation studi…
Sponsor: Huashan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New device aims to starve tumors by cutting off their blood supply
Disease control OngoingThe objective of this study is to evaluate the safety and effectiveness of the GPX® Embolic Device when used as indicated for embolization requiring distal vessel penetration in 114 subjects in up to 25 investigational sites in the USA, New Zealand, and Canada.
Sponsor: Fluidx Medical Technology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a 5-Day therapy help treat anorexia? new trial launches
Symptom relief Recruiting nowThe main aim of this project is to determine the short and long-term effectiveness of an out-patient treatment for patients with anorexia nervosa. Specifically, we will measure whether TBT-S in addition to treatment as usual (TAU) will be more effective than TAU alone in reducing…
Sponsor: Oslo University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Diabetes drug showdown: which combo works best for obese patients?
Disease control CompletedThis study compared the impacts of empagliflozin-metformin, sitagliptin-metformin, and metformin monotherapy in treatment-naive overweight or obese adults with newly diagnosed type 2 diabetes mellitus in Erbil, Iraq. The study monitored participants for 12 weeks. It determined ch…
Phase 4 • Sponsor: Hawler Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Brain zaps show promise for memory in early Alzheimer's
Symptom relief CompletedThe 32 million Alzheimer's disease (AD) and 69 million prodromal AD patients worldwide contribute to a large economic burden. Effective and safe therapies that slow or prevent the progression from mild cognitive impairment (MCI) to AD are therefore of high priority. Transcranial …
Sponsor: Amsterdam UMC, location VUmc • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Can a smart monitor help control diabetes? new study tests CGM in community clinics
Disease control CompletedThis non-randomised, parallel-group pragmatic study used a type 2 effectiveness-implementation hybrid design to evaluate a continuous glucose monitoring (CGM)-assisted community management strategy for adults with type 2 diabetes in Yinzhou District, Ningbo, China. The study was …
Sponsor: Peking University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a 2.5-Hour chat reduce teen pregnancies?
Prevention PausedThe goal of this randomized trial is to learn if the Are You Ready? (AYR) intervention has a positive impact on the sexual and mental health behaviors of sexually active youth between the ages of 14 and 22 years old who are at risk for or involved in the juvenile justice and/or c…
Sponsor: The Policy & Research Group • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Simple urine test could spare lupus patients painful kidney biopsies
Diagnosis Recruiting nowLupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) that can lead to irreversible kidney damage if not detected and managed promptly. LN is classified and treated based on its histopathological features obtained by invasive kidney biopsy. Recent r…
Sponsor: Kolding Sygehus • Aim: Diagnosis
Last updated Jun 26, 2026 14:42 UTC
-
New combo therapy for breast cancer bone metastases enters human testing
Disease control Recruiting nowThe purpose of this study is to test different doses of abemaciclib to find the best dose in participants while receiving hormone therapy and radiation therapy.
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Zap instead of snip: electric pulses may treat Kids' blocked airways
Disease control CompletedThis is a multi-center, prospective, open-label, traditional feasibility study with a before-after study design. The study is designed to evaluate the safety and efficacy of an Irreversible Electroporation (IRE) System for the treatment of upper airway obstruction due to adenoton…
Sponsor: ENTire Medical Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
App-Based therapy for depression put to the test in 325-Person study
Symptom relief Recruiting nowThe project proposes to develop a digital product based on cognitive behavioral therapy for the assisted treatment of depression. The digital cognitive behavioral therapy in this study is conducted based on a self-developed mobile applet. The therapy is developed by psychotherapi…
Sponsor: Peking University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New daily pill shows promise for weight loss in obesity trial
Disease control CompletedThe main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of LY3549492 in adults with obesity or overweight. Participation in the study will last about one year.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Exercise tests may unlock hidden heart risks in fabry disease
Knowledge-focused Recruiting nowThe goal of this observational study is to observe the relation between excercise parameters - assessed by CPET - and rest/stress hemodynamic parameters - assessed by echocardiogram and CMR - in patients with a genetic diagnosis of Anderson-Fabry Disease. Participants will under…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can wearable sensors unlock better blood sugar control after kidney transplants?
Knowledge-focused Recruiting nowThis study examines glucose levels measured by continuous glucose monitoring (CGM) in the immediate period following kidney transplantation among recipients with diabetes, without diabetes, and with pre-diabetes. The primary objective is to analyse differences in mean sensor glu…
Sponsor: Bo Feldt-Rasmussen • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Common antibiotic may stop spread of meningitis bacteria
Disease control CompletedThe purpose of this study is to determine the effectiveness of azithromycin in the eradication of nasopharyngeal carriage of N. meningitidis
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
First human trial launches for DNA vaccine against deadly CCHF virus
Vaccine CompletedThis First-in-human dose-escalation vaccine phase I study aims to evaluate safety and reactogenicity of the investigational vaccine N-pVAX1, against Crimean Congo Hemorrhagic Fever, delivered by in vivo EP given as three im doses at weeks 0, 4 and 12.
Phase 1 • Sponsor: Karolinska Institutet • Aim: Vaccine
Last updated Jun 27, 2026 12:00 UTC
-
Parkinson's patients try lifestyle overhaul: stress, exercise, sleep, and diet targeted
Symptom relief OngoingThe goal of this study is to investigate the effects of a combined lifestyle program on the quality of life in people with Parkinson's Disease. Participants will be randomly assigned to one of two groups, both receiving standard care, a Parkinson Lifestyle Decision aid and an in…
Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Could a simple MRI and blood test predict moyamoya before it strikes?
Knowledge-focused Recruiting nowThis single-center, prospective, family-based observational cohort study aims to investigate susceptibility to moyamoya disease (MMD) and to develop strategies for early screening in individuals at increased familial risk. The study will enroll three groups: patients with MMD, th…
Sponsor: Beijing Tiantan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC